BV
Schedule 13G filing
Biotechnology Value Fund L.P. disclosed a 6.4% stake in FLSC
Biotechnology Value Fund L.P. reported owning 6.4% of Frazier Life Sciences Acquisition Corp. II (FLSC) (500,000 shares) in a Schedule 13G filed Oct 21, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 21, 2026
- Source
- Schedule 13G
More FLSC insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.